logo







Home>Companies>Centessa-pharmaceuticals-nas-cnta


Centessa pharmaceuticals (nas: cnta)

Centessa pharmaceuticals (nas: cnta)



Centessa Pharmaceuticals (NAS: CNTA) is a clinical-stage pharmaceutical company focused on developing innovative therapies for conditions such as hemophilia, solid tumors, narcolepsy, and pulmonary arterial hypertension.
Sign up today to get real-time market insights on Centessa pharmaceuticals (nas: cnta) and hundreds of other pre-IPO companies



Centessa pharmaceuticals (nas: cnta) Overview

2020
Biotech
https://www.centessa.com



Centessa pharmaceuticals (nas: cnta) Live Market Data

$00000000
$00000000




Centessa pharmaceuticals (nas: cnta) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO5/28/2021
Series A1/29/2021




Centessa pharmaceuticals (nas: cnta) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Franklin Templeton (NYS: BEN)Series ASeries A (2021-01-29)
General AtlanticSeries ASeries A (2021-01-29)
Janus Henderson Investors (NYS: JHG)Series ASeries A (2021-01-29)
T. Rowe Price Group (NAS: TROW)Series ASeries A (2021-01-29)
VenrockSeries ASeries A (2021-01-29)
Wellington ManagementSeries ASeries A (2021-01-29)




Centessa pharmaceuticals (nas: cnta) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Centessa pharmaceuticals (nas: cnta) data




Centessa pharmaceuticals (nas: cnta) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Centessa pharmaceuticals (nas: cnta) data




Latest Centessa pharmaceuticals (nas: cnta) News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.